Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-03-14

FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for amlodipine besylate filed by Zydus Pharmaceuticals USA Inc. The action confirms approval of a supplemental submi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate (amlodipine besylate)

Snippet

SUPPL AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)